2 Firms Lead Merck's $11.3B Bio-Techne Life Sciences Deal
Germany's Merck has agreed to acquire Bio-Techne Corp. in an all-cash deal valuing the U.S.-based life sciences tools company at about $11.3 billion, including debt, the companies said Thursday....To view the full article, register now.
Already a subscriber? Click here to view full article